Evaluating the effects of beta blockers on outcomes in traumatic brain injury patients
Official title: Evaluating the Impact of Adjuvant Use of Beta Blockers on Clinical Outcomes in Patients With Traumatic Brain Injury
Run by Mansoura University · NCT06836856 · Data updated 2026-11-12
This study is testing whether beta blockers can help improve recovery for people with moderate to severe traumatic brain injuries.
Quick facts
| Phase | Phase1; Phase2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Mansoura University Academic / other |
| Locations | 2 sites (Zagazig and 1 other locations) |
| Status | Recruiting |
| Started | January 20, 2025 |
| Main results expected | June 2025 |
| Study ends | June 2025 |
| Registry record updated | April 2, 2025 |
| Trial ID | NCT06836856 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients with moderate to severe TBI, as indicated by a GCS score of 13 or lower, who have minimal associated injuries.
✕Probably not a fit
Patients with pre-existing bronchospastic conditions or those on beta-blocker therapy prior to injury may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the impact of adjuvant beta blockers, specifically propranolol and carvedilol, on clinical outcomes in patients suffering from moderate to severe traumatic brain injury (TBI). The study aims to understand how the different receptor blockade profiles of these medications may influence secondary brain injury processes and overall patient recovery. Patients will be monitored for their responses to the treatments compared to a control group, with a focus on improving outcomes for those with TBI. The trial is designed to gather data that could lead to better therapeutic strategies for managing TBI.
Why it matters
Potential benefit: If successful, this study could lead to improved recovery outcomes for patients with traumatic brain injury through the use of beta blockers.
How similar studies have gone: While the use of beta blockers in TBI is a novel approach, preliminary studies have suggested potential benefits, but further investigation is needed to confirm these findings.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1\. Patients with moderate \& severe TBI detected on admission by CT scan and GCS score of ≤ 13 who either do not have any other injuries or only have associated minor injuries. Minor injuries are defined as presence of any of the following: 1. Mild intraperitoneal free fluid (IPFF) observed through abdominal ultrasound. 2. mild lung contusion detected in the chest CT scan. 3. hemothorax or pneumothorax present without accompanying symptoms of hypoxia, tachypnea, or respiratory distress. 4. simple limb fractures. Exclusion Criteria: 1. Patients on pre-injury beta-blocker therapy. 2. Patients with any bronchospastic conditions. 3. Patients with active acute coronary syndrome. 4. TBI with GCS ≤ 13 with associated major injuries defined as the presence of any of the following: 1. Moderate \& marked IPFF requiring surgical intervention ( laparotomy ). 2. moderate \& marked lung contusion, pneumothorax \& hemothorax with accompanying symptoms of hypoxia, tachypnea, lower limbs, or limb amputation. 3. Compound fracture in the upper or lower limb. 4. Open Faciomaxillary trauma. 5. Patients with persistent shock (systemic blood pressure \<100 mmHg, base deficit \> 4, or oliguria , HR \< 60 b/min ) after \> one week of admission.
Where it's running
-
Zagazig University Hospitals, Zagazig,
Zagazig, Egypt Recruiting -
Zagazig University Hospitals
Zagazig, Egypt Not yet recruiting
Study contacts
- Study coordinator: Aya Osama Nagaty
- Email: doctoraya_15@yahoo.com
- Phone: 00201097721011
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ReVIVE for mTBI: Using VR and therapy to help adults with mild traumatic brain injury
This study tests a virtual reality therapy combined with standard psychotherapy to see if it can reduce PTSD symptoms and improve executive function in adults with mild traumatic brain injury.
-
Fibrinogen-to-Albumin Ratio as a Predictor of ARDS in Traumatic Brain Injury
This study tests whether the fibrinogen-to-albumin ratio can predict who among adults with traumatic brain injury will develop acute respiratory distress syndrome (ARDS).
-
Support-TBI: Testing a partner-based program to help people with traumatic brain injury stay connected
A small pilot test will see if a partnered person with TBI and a close supporter can successfully participate in a 12-week program to improve social support and daily life participation.
-
ENGAGE-TBI: A Feasibility Program to Reduce Social Isolation for Adults with Traumatic Brain Injury
We’re testing a 12-session group program to help adults with traumatic brain injury in the community build social participation and reduce isolation.
-
Can a bedside brain scan (fNIRS) detect activity in healthy people and in people with disorders of consciousness
This observational study tests whether functional near-infrared spectroscopy (fNIRS) can measure brain activity at the bedside in healthy adults and in patients with disorders of consciousness in the Neuro-ICU.
-
Long-lasting effects of hyperbaric oxygen therapy on thinking after traumatic brain injury
This project will see if people with traumatic brain injury who completed a course of hyperbaric oxygen therapy 1–4 years ago still have improved thinking and memory.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.